Designing circulating tumor DNA-based interventional clinical trials in oncology
Editorial summary Circulating tumor (ct) DNA is a powerful tool that can be used to track cancer beyond a single snapshot in space and time. It has potential applications in detecting minimal residual disease and predicting relapse, in selecting patients for tailored treatments, and in revealing mec...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Genome Medicine |
Online Access: | http://link.springer.com/article/10.1186/s13073-019-0634-x |